Is telehealth allowed to prescribe Wegovy?

In the evolving landscape of obesity treatment, medications like Wegovy, Ozempic, and Mounjaro have gained significant attention for their effectiveness. With telehealth becoming increasingly mainstream, many patients wonder: Can you legally get weight loss medications through virtual visits? This comprehensive guide covers everything you need to know about accessing GLP-1 medications via telehealth in 2025.

Can You Get Weight Loss Medications Through Telehealth?

Yes, you can legally obtain GLP-1 weight loss medications like Wegovy, Ozempic, or Mounjaro through telehealth in the United States. Since these medications are not controlled substances, federal law does not require an in-person visit before prescribing. This makes them more accessible through virtual care platforms than medications that fall under stricter regulatory frameworks.

While the legal pathway exists, there are important considerations about state regulations, provider qualifications, and what to expect during the telehealth process.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

How Telehealth Prescribing Works for Weight Loss Medications

Getting weight loss medications through telehealth typically follows this process:

1. Virtual Consultation: You’ll schedule a video appointment with a healthcare provider licensed in your state.

2. Medical Evaluation: The provider will assess your health history, current weight, BMI, and any weight-related health conditions.

3. Qualification Assessment: To qualify for GLP-1 medications, you generally need:

• BMI ≥30 (or ≥27 with weight-related conditions like high blood pressure or type 2 diabetes)
• Previous attempts at weight loss through lifestyle changes
• No contraindications (such as personal/family history of medullary thyroid carcinoma)

1. Prescription and Fulfillment: If appropriate, your provider sends an electronic prescription to a pharmacy where you can pick up your medication or have it delivered.

2. Follow-up Care: Regular virtual check-ins to monitor progress, adjust dosage, and address any side effects.

Klarity Health connects patients with licensed providers who can evaluate their candidacy for these medications remotely, making the process convenient while maintaining medical standards.

State-by-State Telehealth Rules for Weight Loss Medications

While telehealth prescribing for GLP-1 medications is broadly available nationwide, state regulations vary:

States with No In-Person Requirements

These states allow full telehealth prescribing without requiring any in-person visits:

• California: Telehealth is explicitly permitted with no in-person exam requirement.
• Connecticut: No in-person mandate; telehealth examination is sufficient.
• Illinois: Permits full telehealth prescribing with no in-person requirement.
• New York: Allows establishing patient-provider relationship via video; no in-person exam needed.
• Washington: Pioneer in telehealth with no in-person requirements for non-controlled medications.

States Requiring Initial In-Person Visits

Some states mandate at least one in-person visit before or during treatment:

• Arkansas: Must perform first examination in-person before telehealth prescribing.
• Delaware: First exam in-person required before telehealth can be used.
• Georgia: In-person exam required prior to telehealth prescribing for weight loss.
• Mississippi: Must see patient once in-person before prescribing weight loss medications.
• North Dakota: Hands-on initial evaluation expected for weight loss treatment.
• South Carolina: Must examine patient in person first before telehealth management.
• Texas: In-person exam generally expected prior to telehealth prescribing.
• Utah: Initial in-person exam encouraged before ongoing telehealth.
• Virginia: Must perform physical exam and labs initially before telehealth management.

States with Special Requirements

Some states have unique rules for weight loss prescribing:

• Florida: Requires BMI ≥30 and follow-up visits at least every 3 months.
• New Jersey: Comprehensive in-person exam, labs, and personalized plan required initially.
• Virginia: Requires initial physical exam, lab work, and personalized diet/exercise plan.

Who Can Prescribe GLP-1 Medications via Telehealth?

Provider qualifications vary by state:

• Physicians (MDs and DOs) can prescribe GLP-1 medications via telehealth in all states, provided they’re licensed where the patient is located.

• Nurse Practitioners (NPs) can prescribe these medications in all states, but their level of independence varies:

• Full Independence: In states like California, Washington, New York, and North Dakota, NPs can prescribe without physician oversight (often after a certain period of experience).

• Collaborative Practice: States like Florida, Illinois, and Pennsylvania require NPs to have collaboration agreements with physicians.

• Restricted Practice: Texas and similar states have more limitations, requiring formal physician agreements.

• Physician Assistants (PAs) can generally prescribe under physician supervision, with specific rules varying by state.

Klarity Health works with appropriately licensed providers in each state, ensuring all prescribers meet state-specific requirements for legal telehealth practice.

Common Misconceptions About Telehealth Weight Loss Treatment

Misconception: ‘Anyone can get weight loss drugs online for quick results.’

Reality: Legitimate telehealth providers screen patients carefully. You must have a clinical need for these medications—generally obesity (BMI ≥30) or overweight (BMI ≥27) with related health conditions. If you don’t meet these criteria, reputable providers will suggest lifestyle changes instead.

Misconception: ‘These are just ‘diet pills’ that can be casually prescribed.’

Reality: GLP-1 medications are not stimulant-based diet pills. They work by regulating appetite and blood sugar through complex hormonal mechanisms. Proper telehealth care includes comprehensive evaluation, monitoring, and setting realistic expectations for gradual weight loss over several months.

Misconception: ‘Telehealth treatment lacks proper medical oversight.’

Reality: Quality telehealth platforms provide the same standard of care as in-person visits, including thorough medical history review, regular follow-ups, and monitoring for side effects. The only difference is the delivery method.

Red Flags to Watch For When Seeking Telehealth Weight Loss Treatment

Be cautious of any telehealth service that:

• Guarantees a prescription without thorough evaluation
• Sells ‘compounded’ versions of semaglutide (FDA banned most compounded Wegovy copies in 2025)
• Doesn’t require follow-ups or monitoring
• Lacks transparency about provider credentials or state licensing
• Skips discussion of risks, side effects, and alternatives
• Asks you to waive your rights or lacks a physical business address

Choose established telehealth providers like Klarity Health that prioritize patient safety and regulatory compliance.

The Future of Telehealth for Weight Loss Medications

Telehealth prescribing of GLP-1 medications appears here to stay, though regulations continue to evolve:

• The pandemic accelerated telehealth adoption, and most states have made permanent changes to accommodate virtual care.
• More states are aligning with flexible telehealth models due to patient demand and positive outcomes.
• Regulators recognize that in-person visit requirements can create barriers to obesity care, especially for patients with mobility issues or those in rural areas.

If you move between states, be aware that licensing rules might differ—your telehealth provider must be licensed in your physical location. Many states have joined interstate compacts to make cross-state telehealth easier.

How to Get Started with Telehealth Weight Loss Treatment

If you’re considering GLP-1 medications for weight management, here are steps to begin:

1. Research providers: Look for established telehealth platforms with licensed providers in your state.

2. Verify insurance coverage: Check if your insurance covers these medications, as they can be expensive without coverage.

3. Prepare for your appointment: Gather information about your weight history, previous weight loss attempts, current medications, and any relevant medical conditions.

4. Be honest during evaluation: Accurate information helps providers determine if these medications are appropriate and safe for you.

5. Ask questions: Understand potential side effects, expected outcomes, and the full treatment plan, including lifestyle modifications.

At Klarity Health, our providers conduct thorough evaluations to determine if GLP-1 medications are appropriate for your situation. We offer convenient scheduling, transparent pricing, and accept both insurance and self-pay options, making quality care accessible to more patients.

Conclusion

Telehealth has made GLP-1 weight loss medications more accessible to patients who medically qualify, though state regulations create some variation in how these services are delivered. By understanding the legitimate pathways to these medications, you can avoid potential pitfalls and ensure

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid